LynkDose LynkDose
Metabolic Growth-hormone C-terminal fragment

Fragment 176-191

Also known as: HGH Fragment 176-191 · Frag 176-191

A short synthetic fragment of the C-terminal region of human growth hormone that is most associated with fat-metabolism and body-composition discussions.

Class

Growth-hormone C-terminal fragment

Default unit

mg

Common route

Subcutaneous

Typical half-life

~30 min

Frequency

Daily

Commonly associated areas

Illustrative map of the body systems Fragment 176-191 is most often discussed in relation to. Relative emphasis only — not a measure of efficacy or a medical claim.

Fat metabolism / lipolysis 88
Body composition 72
Metabolic markers 58
Recovery 40
Growth-hormone effects 34

Proposed mechanisms / pathways

Beta-3 adrenergic signaling Lipolysis in adipose tissue Growth-hormone C-terminal fragment activity

What is Fragment 176-191?

Fragment 176-191 is a short synthetic peptide that corresponds to the C-terminal region (amino acids 176-191) of human growth hormone. The idea behind isolating this fragment is to capture the part of the growth-hormone molecule most associated with fat metabolism while leaving out the segments tied to growth-hormone’s broader effects. It is most commonly discussed in the context of body composition and lipolysis.

How it is thought to work

Fragment 176-191 is thought to act on adipose (fat) tissue, where it is reported to encourage the breakdown of stored fat and to discourage new fat formation, possibly through beta-3 adrenergic pathways. Because it represents only a fragment of the growth-hormone molecule, it is generally described as not raising blood sugar or IGF-1 the way full growth hormone can. These mechanisms are drawn largely from early and preclinical research, so they should be read as proposed rather than settled.

Educational only — not medical advice

This page is educational and is not a recommendation, dose, or medical claim. Fragment 176-191 is a research compound that is not approved for general human use, and nothing here suggests how it should be used — consult a qualified healthcare provider and follow the laws in your area.

Tracking Fragment 176-191 in LynkDose

Fragment 176-191 is a slow-build compound — any change in body composition unfolds over weeks rather than days. In LynkDose, log the dose and time each day, then layer in objective signals like waist measurements, weight, and body-composition data from Apple Health. The value of tracking is watching the fat-loss trend emerge across a full cycle, which a single day never reveals.

Commonly discussed for

  • Fat metabolism and body-composition goals
  • Targeting stored adipose tissue without the broader growth-hormone effects
  • Use within longer metabolic-focused protocols

Often stacked: Sometimes discussed alongside GH-releasing peptides or other metabolic compounds, though it is also used on its own.

How to track Fragment 176-191 in LynkDose

Because changes are gradual, log the dose and time daily and pair them with waist measurements, weight, or body-composition data so the fat-loss trend becomes visible over weeks.

Deeper read: How to Track a Peptide Cycle: A Complete Guide

Not medical advice

This page is educational and does not recommend, prescribe, or dose any compound. Many peptides are research chemicals not approved for general human use. Always consult a qualified healthcare provider and follow the laws in your area.

Related peptides